Online now, and at HAO mart.

TikTok Shop — opens in a new tab @dozoff_sg

HAO mart Outlets across Singapore, listed below

Bring the off switch.

We’re actively looking for distribution partners across Singapore. Dozoff is available at HAO mart outlets today — if you sell drinks, in a shop, on a menu, or online, we’d like to hear from you.

Apply to distribute
— back to the top
A block of flats at dusk, one window lit.

A Singapore block of flats at dusk. Night falls and one window lights warm; inside, a bedside lamp, a wooden nightstand, and a chilled Dozoff peach tea can. Morning returns.

Rest. Relax. Switch off.

Singapore

Your day can end here.

A non-carbonated peach tea relaxation drink. Now in Singapore.

Shop on TikTok — opens in a new tab Find it in store

The world has enough drinks that switch you on. This is the part after.

A slim can, a quiet hour.

Dozoff is a non-carbonated peach tea relaxation drink in a 250 ml slim can.

The brand comes from Malaysia, where it won Best Functional Beverage Brand at the ASEAN Food & Travel Award 2024. It is now arriving in Singapore.

Meet the founder

What’s inside

Four things, named plainly.

L-Theanine · Magnesium · Valerian Root · Vitamin B6

L-Theanine — the research behind it

The quiet note found in green tea.

An amino acid that occurs naturally in tea leaves. Studied for attention and for stress; the best-evidenced of the four here.

Simple ingredients. Rest and relax.

Full ingredient list on can. Not a medicinal product. Read the research

Online now, and at HAO mart.

Online now

  • TikTok Shop@dozoff_sg
Shop on TikTok — opens in a new tab

In store now

  • HAO martOutlets across Singapore, listed below
See the outlets
Indicative map of Singapore: HAO mart outlets stocking Dozoff, plotted from their coordinates. Each is listed in full below. HAO mart Bedok South — East HAO mart Canberra Link — North HAO mart Potong Pasir — Central HAO mart Petir Road — West HAO mart Whampoa Drive — Central HAO Halal Hub Pasir Ris — East Eccellente by HAO mart, Marina Square — Central
Drag to move around · Ctrl + scroll to zoom · on a phone, pinch.

East

North

Central

West

Stock varies by outlet; call ahead for large quantities.

Bring the off switch.

We’re actively looking for distribution partners across Singapore. Dozoff is available at HAO mart outlets today — if you sell drinks, in a shop, on a menu, or online, we’d like to hear from you.

Apply to distribute
Back to the site

Showing our work

We did the reading.

Four ingredients, sixteen peer-reviewed human studies. Every one of them is set out here in full — what it looked at, how big it was, what it found, and where it came up short.

Compiled 1 August 2026. Every reference was confirmed against the PubMed record and, where a DOI is registered, against the publisher’s own metadata — nothing here is reconstructed from memory. Where a study was null, weak or mixed, or where its own authors flagged the quality of the evidence, that is on the page too, at the end of each ingredient.

L-Theanine

Strength of evidenceModerate evidence

A meta-analysis of 31 randomised trials found a real short-term effect on attention and a modest reduction in stress that its authors judged to be influenced by bias; a placebo-controlled crossover trial in healthy adults found significantly improved sleep-quality scores. The pooled effect on anxiety was not significant, and the sleep-specific evidence rests on a handful of small trials.

1.3Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial

Authors
Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, Kunugi H (7 authors)
Journal
Nutrients, 2019; 11(10): 2362
Study type
Randomised, placebo-controlled, double-blind crossover trial
Sample
30 healthy adults (9 men, 21 women; mean age 48.3 ± 11.9 years) with no major psychiatric illness. 200 mg/day for 4 weeks.
Identifiers
DOI 10.3390/nu11102362 · PMID 31623400

What it foundScores for depression, trait anxiety and sleep quality (PSQI) all decreased significantly after L-theanine (p = 0.019, 0.006 and 0.013 respectively), with improvements in sleep latency, sleep disturbance and use of sleep medication. Verbal fluency and executive function also improved, chiefly in participants with lower baseline scores. This is a small, 30-person crossover study — it is the most directly sleep-relevant L-theanine RCT in healthy adults, but it is not large.

PubMed 31623400 — opens in a new tabDOI 10.3390/nu11102362 — opens in a new tab

1.1Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials

Authors
Gerolymos C, Saddier E, Boyer L, Fond G (4 authors)
Journal
Molecular Psychiatry, 2026 (published online 6 July 2026; volume/pages not yet assigned)
Study type
Systematic review and meta-analysis of randomised controlled trials
Sample
31 RCTs, n = 1,168; healthy and clinical populations. Typical dosing 200 mg single dose; one trial used 400 mg/day for 8 weeks.
Identifiers
DOI 10.1038/s41380-026-03727-9 · PMID 42410082

What it foundA single dose significantly improved choice reaction time (SMD = 0.51), and the pooled effect on stress was modest (SMD = 0.31) and, in the authors’ own assessment, influenced by bias. Effects on anxiety were inconsistent and non-significant, and there was no significant effect on fatigue; a reduction in depressive symptoms (SMD = 0.69, after excluding one outlier) was reported as needing confirmation. No serious adverse events.

NoteThis is the largest and most rigorous L-theanine synthesis available, but it evaluates cognitive and affective outcomes — it is not a review of sleep outcomes, and its anxiety result is null.

PubMed 42410082 — opens in a new tabDOI 10.1038/s41380-026-03727-9 — opens in a new tab

1.2The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review

Authors
Williams JL, Everett JM, D’Cunha NM, Sergi D, Georgousopoulou EN, Keegan RJ, McKune AJ, Mellor DD, Anstice N, Naumovski N (10 authors)
Journal
Plant Foods for Human Nutrition, 2020; 75(1): 12–23
Study type
Systematic review of randomised controlled trials
Sample
9 peer-reviewed studies comparing pure L-theanine supplementation against a control; doses 200–400 mg/day.
Identifiers
DOI 10.1007/s11130-019-00771-5 · PMID 31758301

What it foundThe reviewers concluded that L-theanine supplementation may assist in reducing stress and anxiety in people exposed to stressful conditions. They explicitly called for longer-term studies in larger cohorts, i.e. the finding is suggestive rather than settled.

PubMed 31758301 — opens in a new tabDOI 10.1007/s11130-019-00771-5 — opens in a new tab

Null and mixed resultsNot every trial found an effect: in adults with a diagnosis of generalised anxiety disorder, L-theanine did not outperform placebo on anxiety or on insomnia severity — though self-reported sleep satisfaction did improve — and across the 31 pooled trials the effect on anxiety was inconsistent and not significant. The sleep-specific evidence base is small, and still developing.

Magnesium

Strength of evidenceMixed — still being studied

A meta-analysis of three randomised trials found participants fell asleep about 17 minutes sooner than those given placebo, and a placebo-controlled trial in older adults with insomnia reported significant improvements in sleep time, sleep efficiency and insomnia severity. Both sit on a thin base: the pooled trials are small, and their own authors grade the evidence low to very low quality.

2.1Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis

Authors
Mah J, Pitre T (2 authors)
Journal
BMC Complementary Medicine and Therapies, 2021; 21(1): 125
Study type
Systematic review and meta-analysis of RCTs
Sample
3 randomised controlled trials, n = 151 older adults.
Identifiers
DOI 10.1186/s12906-021-03297-z · PMID 33865376

What it foundPooled analysis showed sleep onset latency reduced by 17.36 minutes versus placebo (p = 0.0006), while the 16.06-minute improvement in total sleep time was not statistically significant. The authors state plainly that all trials were at moderate-to-high risk of bias and the outcomes were supported by low to very low quality evidence. Their case for magnesium rests partly on it being cheap and safe rather than on strong efficacy data.

PubMed 33865376 — opens in a new tabDOI 10.1186/s12906-021-03297-z — opens in a new tab

2.4The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial

Authors
Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B (6 authors)
Journal
Journal of Research in Medical Sciences, 2012; 17(12): 1161–1169
Study type
Randomised, double-blind, placebo-controlled clinical trial
Sample
46 elderly subjects with primary insomnia; 500 mg magnesium daily or placebo for 8 weeks.
Identifiers
PMID 23853635 · PMCID PMC3703169 · DOI: none registered for this article — PMID and PMCID serve as the persistent identifiers.

What it foundThe magnesium group showed statistically significant improvements in sleep time (p = 0.002), sleep efficiency (p = 0.03), Insomnia Severity Index score (p = 0.006) and sleep onset latency (p = 0.02), alongside higher serum melatonin (p = 0.007) and lower serum cortisol (p = 0.008). Caveat: this is a small single-centre trial in elderly insomnia patients, and it is one of the three trials that the Mah & Pitre meta-analysis (2.1) rated at moderate-to-high risk of bias.

PubMed 23853635 — opens in a new tabPMC3703169 — opens in a new tab

Null and mixed resultsNot every trial found an effect: a systematic review of nine studies concluded that the randomised evidence on magnesium and sleep is contradictory and the association uncertain, and a review of eighteen studies in anxiety-prone groups found mixed results — roughly half reported a benefit — with its reviewers describing the quality of the existing evidence as poor. The evidence base is still developing.

Valerian Root (Valeriana officinalis)

Strength of evidenceMixed — still being studied

Meta-analyses consistently find an improvement in subjectively rated sleep quality, and safety is consistently good across every review here. Those same reviews disagree with one another on efficacy, find no effect on objectively measured sleep latency, and document both publication bias and variable quality in the extracts tested.

Valerian is the ingredient where the published literature most openly disagrees with itself. All four references below are systematic reviews or meta-analyses, and they are presented together precisely because they do not reach the same conclusion.

3.3Valerian Root in Treating Sleep Problems and Associated Disorders—A Systematic Review and Meta-Analysis

Authors
Shinjyo N, Waddell G, Green J (3 authors)
Journal
Journal of Evidence-Based Integrative Medicine, 2020; 25: 2515690X20967323
Study type
Systematic review and meta-analysis
Sample
60 studies, n = 6,894 total; meta-analysis included 10 studies (n = 1,065) for sleep quality and 8 studies (n = 535) for anxiety.
Identifiers
DOI 10.1177/2515690X20967323 · PMID 33086877

What it foundThe authors concluded valerian could be a safe and effective herb to promote sleep and reduce anxiety, but attributed the inconsistent outcomes across trials to variable quality of the herbal extracts used, suggesting more reliable effects would be expected from whole root/rhizome preparations. They explicitly called for revised standardisation and quality-control processes. No severe adverse events were associated with valerian intake.

PubMed 33086877 — opens in a new tabDOI 10.1177/2515690X20967323 — opens in a new tab

3.1Valerian for sleep: a systematic review and meta-analysis

Authors
Bent S, Padula A, Moore D, Patterson M, Mehling W (5 authors)
Journal
The American Journal of Medicine, 2006; 119(12): 1005–1012
Study type
Systematic review and meta-analysis of randomised placebo-controlled trials
Sample
16 eligible studies, 1,093 patients.
Identifiers
DOI 10.1016/j.amjmed.2006.02.026 · PMID 17145239

What it foundSix studies reporting a dichotomous sleep-quality outcome showed a statistically significant benefit (relative risk of improved sleep = 1.8, 95% CI 1.2–2.9) — but the analysis showed evidence of publication bias, most studies had significant methodological problems, and doses, preparations and treatment duration varied considerably. The authors’ conclusion was hedged: valerian might improve sleep quality without side effects.

PubMed 17145239 — opens in a new tabDOI 10.1016/j.amjmed.2006.02.026 — opens in a new tab

3.2Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials

Authors
Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G (6 authors)
Journal
Sleep Medicine, 2010; 11(6): 505–511
Study type
Meta-analysis of randomised placebo-controlled trials
Sample
18 RCTs (8 of which scored the maximum 5 on the Jadad quality scale).
Identifiers
DOI 10.1016/j.sleep.2009.12.009 · PMID 20347389

What it foundSubjective sleep quality improved versus placebo (RR = 1.37, 95% CI 1.05–1.78), but the effect on sleep latency was essentially zero (mean difference 0.70 minutes, 95% CI −3.44 to 4.83). The authors concluded valerian appears effective for a subjective improvement in insomnia, and that its effectiveness has not been demonstrated on quantitative or objective measurements.

PubMed 20347389 — opens in a new tabDOI 10.1016/j.sleep.2009.12.009 — opens in a new tab

Null and mixed resultsThe reviews do not agree: one systematic review of 37 studies found that most showed no significant difference between valerian and placebo, and concluded the evidence does not support clinical efficacy as a sleep aid for insomnia — it is titled “safe but not effective”. The improvements above are in subjectively rated sleep rather than objectively measured sleep latency, and the evidence base is still developing. Safety is the one thing every review here agrees on.

Vitamin B6 (Pyridoxine)

Strength of evidenceEarly-stage evidence

A randomised trial in young adults found that a high dose of B6 reduced self-reported anxiety, alongside a marker its authors read as increased inhibitory GABA activity, consistent with B6’s known role in GABA synthesis. Sleep is the gap: no trial here shows that B6 on its own improves sleep quality, and the remaining sleep signal is cross-sectional association only.

Read this first. Vitamin B6 has the thinnest sleep-specific evidence base of the four ingredients. There is no meta-analysis of B6 for sleep quality. The strongest human data concern anxiety and stress, not sleep — and two of the four references below test B6 in combination with magnesium, so their effects cannot be attributed to B6 alone.

4.1High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression

Authors
Field DT, Cracknell RO, Eastwood JR, Scarfe P, Williams CM, Zheng Y, Tavassoli T (7 authors)
Journal
Human Psychopharmacology: Clinical and Experimental, 2022; 37(6): e2852
Study type
Randomised, double-blind, placebo-controlled trial (five linked phases)
Sample
478 young healthy adults recruited; analysed subsets of n = 265 (anxiety), n = 146 (depression), n = 307 (visual surround suppression). High-dose vitamin B6 vs vitamin B12 vs placebo, 1 month.
Identifiers
DOI 10.1002/hup.2852 · PMID 35851507

What it foundHigh-dose vitamin B6 reduced self-reported anxiety and increased surround suppression of visual contrast detection — a marker the authors interpret as increased inhibitory GABAergic neural activity, consistent with B6’s known role in GABA synthesis. B12 produced only trends toward change. B6 did not reliably influence binocular rivalry or tactile sensitivity. This trial did not measure sleep.

PubMed 35851507 — opens in a new tabDOI 10.1002/hup.2852 — opens in a new tab

4.4Association of Pyridoxal 5′-Phosphate with Sleep-Related Problems in a General Population

Authors
Ge L, Luo J, Zhang L, Kang X, Zhang D (5 authors)
Journal
Nutrients, 2022; 14(17): 3516
Study type
Cross-sectional observational study (NHANES 2005–2010). Observational — shows association only, not causation.
Sample
US general adult population sampled by NHANES 2005–2010. The abstract does not state a single headline participant count, so none is asserted here.
Identifiers
DOI 10.3390/nu14173516 · PMID 36079774

What it foundHigher serum pyridoxal 5′-phosphate (the active form of B6) was associated with lower odds of daytime sleepiness (Q2 OR = 0.76, 95% CI 0.59–0.99; Q3 OR = 0.78, 95% CI 0.62–0.98) and with lower risk of very short, short and long sleep duration (e.g. RRR = 0.58, 95% CI 0.43–0.81 for Q4 vs very short sleep). The daytime-sleepiness association was significant only in males.

PubMed 36079774 — opens in a new tabDOI 10.3390/nu14173516 — opens in a new tab

Null and mixed resultsThis is the thinnest evidence base of the four, and the closing note is longer than the rest for that reason. Adding B6 to magnesium was no better than magnesium alone across a full study population, with a difference appearing only in a pre-specified severe-stress subgroup and no placebo arm to compare against; and the one randomised trial to look directly at sleep found more dream content recalled but no improvement in sleep quality, with its B-complex arm reporting worse sleep and more morning tiredness. No study here shows that B6 on its own improves sleep quality.

  • 4.2Pouteau E, Kabir-Ahmadi M, Noah L, et al. “Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial.” PLOS ONE, 2018; 13(12): e0208454. Both arms improved with no significant difference overall (p > 0.05); no placebo arm — both groups received magnesium. PubMed 30562392 — opens in a new tabDOI 10.1371/journal.pone.0208454 — opens in a new tab
  • 4.3Adventure-Heart DJ, Madden NA, Delfabbro P. “Effects of Vitamin B6 (Pyridoxine) and a B Complex Preparation on Dreaming and Sleep.” Perceptual and Motor Skills, 2018; 125(3): 451–462. B6 increased dream content recalled but did not affect vividness, bizarreness or colour; the B complex group reported significantly lower self-rated sleep quality and greater morning tiredness than controls. PubMed 29665762 — opens in a new tabDOI 10.1177/0031512518770326 — opens in a new tab

How these were found and checked

Searching. Structured queries were run against the PubMed / NCBI E-utilities API for each ingredient crossed with sleep, insomnia, sleep quality, stress, anxiety and relaxation terms, filtered where possible to the publication types Meta-Analysis, Systematic Review and Randomized Controlled Trial. Candidate records were then pulled in full for their bibliographic metadata and abstracts.

Verification. Every reference above was confirmed against at least two independent authoritative sources: the PubMed E-utilities record, which confirms PMID, exact title, author list, journal, year, volume, issue, pages, DOI and publication type; and the Crossref REST API or the DOI resolver landing on the publisher’s own record, which confirms the DOI is registered and that the registered metadata matches.

Summaries. Every plain-English summary above is drawn from the article’s own published abstract. Where a study was null, weak, mixed, or where the authors themselves flagged poor evidence quality, that is stated explicitly rather than smoothed over. Nothing has been upgraded in tone.

Looked for, and deliberately left out

Excluded because non-human

  • Dasdelen MF et al. “A Novel Theanine Complex, Mg-L-Theanine Improves Sleep Quality via Regulating Brain Electrochemical Activity.” Frontiers in Nutrition, 2022; 9: 874254. DOI 10.3389/fnut.2022.874254; PMID 35449538. The record is genuine and verified, but the study uses caffeine-induced and pentobarbital-induced animal sleep models. Excluded per the animal-only rule despite being the most on-brief title found — it directly combines magnesium and L-theanine.
  • Jung HY et al., “Pyridoxine Deficiency Exacerbates Neuronal Damage after Ischemia…” Int J Mol Sci, 2020; 21(15): 5551. Gerbil study. Excluded.
  • Multiple in-vitro GABA-receptor and rodent EEG papers surfaced in the theanine and valerian searches; all excluded without individual listing.

Excluded because the evidence type is too weak to cite as support

  • Mendelian randomisation studies on micronutrients and insomnia (e.g. PMID 41305687; PMID 39910798). Genuine and human, but genetic-proxy designs are easily misread by consumers as showing a supplement effect, which they do not.
  • Narrative (non-systematic) reviews, including Rao TP, Ozeki M, Juneja LR, “In Search of a Safe Natural Sleep Aid,” J Am Coll Nutr 2015; 34(5): 436–447 (DOI 10.1080/07315724.2014.926153; PMID 25759004). Verified as real, but a narrative review sits below the RCT / systematic-review bar set for this page.
  • Multi-ingredient proprietary formula trials where the contribution of any single ingredient cannot be isolated — e.g. Noah L et al., “Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals,” Nutrients 2022; 14(9): 1863 (PMID 35565828), and Gong J et al. on walnut peptide + theanine (PMID 41531275).

Excluded because they could not be verified

  • Two references initially drawn from memory turned out to be entirely different papers when checked against PubMed, and were discarded. PMID 21196184 is a paper on endocannabinoids and reproduction, not the Barton valerian trial; PMID 29565223 is a paper on predicting biathlon shooting performance with machine learning, not the vitamin B6 dreaming study. Both correct articles were subsequently located and verified under their true PMIDs (21399726 and 29665762). This is recorded here as evidence that every identifier on this page was checked rather than recalled.
  • No reference appears on this page for which a DOI or PMID could not be confirmed against a live index.

Verified as real, but not included — only because of the four-per-ingredient cap

  • Lyon MR, Kapoor MP, Juneja LR. “The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.” Alternative Medicine Review, 2011; 16(4): 348–354. PMID 22214254. No DOI registered; journal ceased publication in 2013. RCT, n = 98 boys aged 8–12; improved actigraphy-measured sleep percentage and efficiency, sleep latency unchanged.
  • Barton DL et al. “The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).” The Journal of Supportive Oncology, 2011; 9(1): 24–31. DOI 10.1016/j.suponc.2010.12.008; PMID 21399726. n = 227 randomised; missed its primary endpoint — PSQI area under curve 51.4 vs 49.7, p = 0.6957 — with some secondary fatigue endpoints favouring valerian in exploratory analysis. The largest placebo-controlled valerian sleep trial, and it was null.
  • Zhang Y et al. “Association of magnesium intake with sleep duration and sleep quality: findings from the CARDIA study.” Sleep, 2022; 45(4): zsab276. DOI 10.1093/sleep/zsab276; PMID 34883514. Observational, n = 3,964; higher magnesium intake only borderline associated with better sleep quality, OR = 1.23, p = 0.051.
  • Noah L et al. “Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial.” Stress and Health, 2021; 37(5): 1000–1009. DOI 10.1002/smi.3051; PMID 33864354.
  • Jadidi A et al. “Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial.” BMC Complementary Medicine and Therapies, 2022; 23(1): 1. DOI 10.1186/s12906-022-03814-8; PMID 36587225. n = 75; single-blind; sleep quality differed significantly only in the second month.
  • Moshfeghinia R et al. “The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review.” BMC Psychiatry, 2024; 24(1): 886. DOI 10.1186/s12888-024-06285-y; PMID 39633316.
  • Wyatt KM et al. “Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review.” BMJ, 1999; 318(7195): 1375–1381. DOI 10.1136/bmj.318.7195.1375; PMID 10334745. Real and strong, but PMS rather than sleep or general relaxation.

Switch off. Wake ready.

A non-carbonated peach tea relaxation drink in a 250 ml slim can.

Contact

2 Venture Drive
#14-02 Vision Exchange
Singapore 608526

© 2026 Dozoff Singapore A brand of Renew Wellness Sdn Bhd

Dozoff is a drink, not a medicinal product. Full ingredient list on can.

Privacy Policy

Back to the site
Back to the site

About

A slim can, a quiet hour.

Dozoff is a non-carbonated peach tea relaxation drink in a 250 ml slim can.

The brand comes from Malaysia, where it won Best Functional Beverage Brand at the ASEAN Food & Travel Award 2024. It is now arriving in Singapore.

Chin Wui Khong, co-founder of Dozoff.

Chin Wui Khong

Co-founder, Dozoff

Chin Wui Khong is a co-founder of Dozoff. A finance graduate of Universiti Malaya, he works across category creation, retail strategy and FMCG operations in Southeast Asia — building a consumer brand around the part of the day most drinks ignore.

Switch off. Wake ready.

A non-carbonated peach tea relaxation drink in a 250 ml slim can.

Contact

2 Venture Drive
#14-02 Vision Exchange
Singapore 608526

© 2026 Dozoff Singapore A brand of Renew Wellness Sdn Bhd

Privacy Policy

Back to the site
Back to the site

Journal

What the brand has been up to.

Switch off. Wake ready.

A non-carbonated peach tea relaxation drink in a 250 ml slim can.

Contact

2 Venture Drive
#14-02 Vision Exchange
Singapore 608526

© 2026 Dozoff Singapore A brand of Renew Wellness Sdn Bhd

Privacy Policy

Back to the site
Back to the site

Trade enquiries

Bring the off switch.

We’re actively looking for distribution partners across Singapore. Dozoff is available at HAO mart outlets today — if you sell drinks, in a shop, on a menu, or online, we’d like to hear from you.

Retailers, wholesalers, F&B operators and e-commerce sellers are all invited to apply.

Retailers

Convenience, grocery, pharmacy and specialty shelves.

Wholesalers

Trade supply into the outlets a single listing will never reach.

F&B operators

Cafes, restaurants, hotels, gyms and workplace pantries.

E-commerce sellers

Marketplaces, your own storefront, and social commerce.

Partners

Who brings it here.

Retail

  • HAO mart (Singapore)

Distribution

  • Yakin Distribution (Singapore)

Malaysia

  • Dozoff Malaysia
  • Renew Wellness Sdn Bhd

Apply to distribute

Read the Privacy Policy

Switch off. Wake ready.

A non-carbonated peach tea relaxation drink in a 250 ml slim can.

Contact

2 Venture Drive
#14-02 Vision Exchange
Singapore 608526

© 2026 Dozoff Singapore A brand of Renew Wellness Sdn Bhd

Privacy Policy

Back to the site
Back to the site

Dozoff Singapore

Privacy Policy

About this policy

This policy explains how [Singapore operating entity name] (UEN [UEN]) (“Dozoff”, “we”, “us” or “our”) handles personal data through the Dozoff Singapore website and related enquiries. We follow Singapore’s Personal Data Protection Act 2012, as amended, including the 2020 amendments (the “PDPA”).

Dozoff is a brand of its parent company, Renew Wellness Sdn Bhd in Malaysia. This website has no user accounts or checkout. Purchases take place on TikTok Shop under its own privacy terms; we do not collect payment-card or checkout details through this website.

Personal data we collect

Depending on how you interact with us, we may collect:

  • Distributor application information: your name, role, company and registration details, email address, telephone or WhatsApp number, business information, and application or message contents.
  • Contact information: your name, email address, telephone number (if you provide it), and the contents of your enquiry when you use a contact form or another enquiry channel.
  • Basic website and analytics information: data sent by your browser or device, such as IP address, browser or device type, referring page, pages viewed, and visit date and time.

If you give us another person’s data, you should be authorised to provide it and allow us to handle it as described here.

Why and how we use personal data

We collect, use and disclose personal data only for purposes that we notify to you and that a reasonable person would consider appropriate. These purposes are to:

  • respond to enquiries and communicate about them;
  • assess, process and follow up on distributor or trade applications;
  • operate, secure and understand use of the website;
  • manage relationships with applicants and business contacts; and
  • meet legal, regulatory, record-keeping and dispute-resolution requirements.

We generally rely on consent given when you submit information for a notified purpose. We will seek fresh consent for a materially different purpose unless law permits or requires otherwise. We will not make an unrelated use a condition of responding to you, and we do not sell personal data.

Cookies and analytics

We use cookies or similar technologies to operate the website and for basic analytics, such as understanding page visits and site performance. You can control cookies in your browser, although blocking them may affect some functions. Where required, we will notify you and obtain consent.

Sharing and overseas transfers

We may disclose personal data only where reasonably needed for the purposes above, including to:

  • Renew Wellness Sdn Bhd in Malaysia;
  • providers supporting hosting, analytics, forms, email, storage, security or other operations; and
  • regulators, courts, law-enforcement bodies or advisers where disclosure is permitted by law or needed to protect legal rights.

Some recipients or systems may be overseas, including in Malaysia. For an overseas transfer, we use contractual or other legally recognised safeguards to ensure protection comparable to the PDPA. Service providers may use the data only to provide their service or as permitted by law.

Accuracy, protection and retention

We make reasonable efforts to keep personal data accurate and complete, especially before a decision affecting you or disclosure to another organisation. Please tell our Data Protection Officer (“DPO”) if details change.

We use reasonable administrative, technical and physical safeguards against unauthorised access, collection, use, disclosure, copying, modification, loss, disposal or similar risks. No system can be completely secure.

We retain personal data only while needed for its purpose or a legal or business need, considering the status of an enquiry or application, record-keeping duties and possible disputes. We then delete, anonymise or securely dispose of it.

Telephone and message marketing

If we conduct marketing by voice call, SMS or another message sent to a Singapore telephone number, we will comply with the PDPA’s Do Not Call (DNC) provisions. Unless an exception applies or you have given clear and unambiguous consent, we will check the relevant DNC Register before sending a marketing message. We will identify ourselves, provide contact or opt-out information as required, not conceal a caller’s identity, and honour opt-out requests within the legally required period. Operational replies about an enquiry or application are not marketing messages.

Data breaches

If a personal data breach occurs, we will take steps to contain and assess it. If the breach is likely to cause significant harm or is of significant scale, we will notify Singapore’s Personal Data Protection Commission (“PDPC”) within the period required by the PDPA. Where required, we will also notify affected individuals as soon as practicable. These mandatory breach-notification requirements were introduced through the 2020 amendments.

Contact our Data Protection Officer

Our DPO oversees our data-protection practices and handles requests and complaints. Contact:

Data Protection Officer
[Singapore operating entity name]
Email: [DPO email]
Registered address: 2 Venture Drive, #14-02 Vision Exchange, Singapore 608526

If you have a concern, please contact our DPO first so that we can review it. You may also contact the PDPC through its official website at https://www.pdpc.gov.sg/ — opens in a new tab.

Changes to this policy

We may update this policy to reflect changes to our practices or legal requirements. The latest version will be posted on this page with its effective date.

Switch off. Wake ready.

A non-carbonated peach tea relaxation drink in a 250 ml slim can.

Contact

2 Venture Drive
#14-02 Vision Exchange
Singapore 608526

© 2026 Dozoff Singapore A brand of Renew Wellness Sdn Bhd

Privacy Policy

Back to the site